Selective photo-cross-linking of 2′-O-psoralen-conjugated oligonucleotide with RNAs having point mutations

Nucleosides, Nucleotides and Nucleic Acids

Volumn 26, Issue 3, 2007, Pages 277-290

  Higuchi, Maiko ^a   Yamayoshi, Asako ^b   Yamaguchi, Takasei ^a   Iwase, Reiko ^c   Yamaoka, Tetsuji ^d   Kobori, Akio ^a   Murakami, Akira ^a  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY OF SCIENCE   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Antisense oligonucleotide; Photo cross linking; Point mutation; Psoralen; Ras

Indexed keywords

2' O [(4,5',8 TRIMETHYL)PSORALEN 4' YLMETHYL]ADENOSINE; 6 N BENZOYL 2' O [(4,5',8 TRIMETHYL)PSORALEN 4' YLMETHYL]ADENOSINE; 6 N BENZOYL 5' O DIMETHOXYTRITYL 2' O [(4,5',8 TRIMETHYL)PSORALEN 4' YLMETHYL]ADENOSINE; 6 N BENZOYL 5' O DIMETHOXYTRITYL 2' O [(4,5',8 TRIMETHYL)PSORALEN 4' YLMETHYL]ADENOSINE 3' (2 CYANOETHYL N, N' DIISOPROPYLPHOSPHORAMIDITE); ADENOSINE DERIVATIVE; ANTISENSE OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDE; OLIGORIBONUCLEOTIDE; PSORALEN; PYRIMIDINE; UNCLASSIFIED DRUG;

ARTICLE; CONJUGATION; DNA CROSS LINKING; DRUG SELECTIVITY; DRUG SYNTHESIS; GENE SEQUENCE; POINT MUTATION;

CHEMISTRY; CROSS-LINKING REAGENTS; FICUSIN; LIGHT; MODELS, CHEMICAL; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; POINT MUTATION; RNA; TEMPERATURE; ULTRAVIOLET RAYS;

EID: 34147130198     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770701257434     Document Type: Article

References (38)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004, 431, 931-945.
2. The FANTOM Consortium, RIKEN Genome Exploration Research Group and Genome Science Group. The transcriptional landscape of the mammalian genome. Science 2005, 309, 1559-1563.
3. RIKEN Genome Exploration Research Group, Genome Science Group and the FANTOM Consortium. Antisense transcription in the mammalian transcriptome. Science 2005, 309, 1564-1566.
4. Kurreck, J. Antisense technologies. Eur. J. Biochem. 2003, 207, 1628-1644.
5. Hutvagner, G.; Simard, M.J.; Mello, C.C.; Zamore, P.D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2004, 2, 465-475.
6. Meister, G.; Landthaler, M.; Dorsett, Y.; Tuschl, T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 2006, 10, 544-550.
7. Zhao, Y.; Samal, E.; Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436, 214-220.
8. Krutzfelds, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438, 685-689.
9. Weiler, J.;Hunziker, J.; Hall, J. Anti-miRNA oligonucleotides(AMOs) : Ammunition to target miRNAs implicated in human disease? Gene Therapy 2006, 13, 496-502.
10. Patil, S.D.; Rhodes, D.G.; Burgess, D.J. DNA-based therapeutics and DNA delivery systems: A comprehensive review. AAPS J . 2005, 7, E61-E77.
11. Crooke, S.T. Vitravene - another piece in the mosaic. Antisense Nucleic Acid Drug Dev. 8, 1998, vii-viii.
12. Iwase, R.; Yamayoshi, A.; Nishida, J.; Yamaoka, T.; Wake, N.; Murakami, A. Photodynamic antisense regulation using psoralen-conjugated oligo(nucleoside phosphorothioate)s (I). Growth regulation of cervical carcinoma cells. Nucleic Acids Symposium Series 1999, 42, 223-224.
13. Cimino, G.D.; Gamper, H.B.; Isaacs, S.; Hearst, J. Psoralen as photoactive probes of nucleic acid structure and function: Organic chemistry, photochemistry, and biochemistry. Ann. Rev. Biochem. 1985, 54, 1151-1193.
14. Gleave,M.E.; Monia, B.P. Antisense therapy for cancer. Nat. Rev. Canc. 2005, 5, 468-479.
15. Kurreck, J. Antisense technologies. Eur. J. Biochem. 2003, 270, 1628-1644.
16. Shaw, J.P.; Kent, K.; Bird, J.; Fishback, J.; Froehler, B. Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res. 1991, 19, 747-750.
17. Murakami, A.; Yamayoshi, A.; Iwase, R.; Nishida, J.; Yamaoka, T.; Wake, N. Photodynamic antisense regulation of human cervical carcinoma cell growth using psoralen-conjugated oligo(nucleoside phosphorothioate). Eur. J. Pharma. Sci. 2001, 13, 25-34.
18. Barbacid, M. ras genes. Ann. Rev. Biochem. 1987, 56, 779-827.
19. Bos, J.L.; Fearon, E.R.; Hamilton, S.R. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987, 327, 293-297.
20. Kahn, S.; Yamamoto, F.; Almoguera, C.; Winter, E.; Forrester, K.; Jordano, J. Perucho, M. The c-K-ras gene and human cancer (Review). Anticancer Res. 1987, 7, 639-652.
21. Mukhopadhyay, T.; Tainsky, M.; Cavender, A.C.; Roth, J.A. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res. 1991, 51, 1744-1748.
22. Georges, R.N.; Mukhopadhyay, T.; Zhang, Y.; Yen, N.; Roth, J.A. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res. 1993, 53, 1743-1746.
23. Zhang, Y.; Mukhopadhyay, T.; Donehower, L.A.; George, R.N.; Roth, J.A. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Human Gene Therapy 1993, 4, 451-460.
24. Aoki, K.; Yoshida, T.; Sugimura, T.; Terada, M. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. Cancer Res. 1995. 55, 3810-3816.
25. Cowsert, L.M. In vitro and in vivo activity of antisense inhibitors of ras: Potential for clinical development. Anti-Cancer Drug Dev. 1997, 12, 359-371.
26. Lee, B.L.; Murakami, A.; Blake, K.R.; Lin, S.; Miller, P.S. Interaction of psoralen-derivatized oligodeoxyribonucleoside methylphosphonates with single-stranded DNA. Biochemistry 1988, 27, 3197-3203.
27. Isaacs, S.T.; Shen, C.J.; Hearst, J.E.; Rapoport, H. Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA. Biochemistry 1977, 16, 1058-1064.
28. Ti, G.S.; Gaffney, B.L.; Jones, R.A. Transient protection: Efficient one-flask syntheses of protected deoxynucleosides. J. Am. Chem. Soc. 1982, 104, 1316-1319.
29. Nielsen, P.E.; Egholm, M.; Berg, R.H.; Buchardt, O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 1991, 254, 1497-1500.
30. Summerton, J. Morpholino antisense oligomers: The case for an RNase H-independent structural type. Biochim. Biophys. Acta. 1999, 1489, 141-158.
31. Obika, S.; Nanbu, D.; Hari, Y.; Andoh, J.; Morio, K.; Doi, T.; Imanishi, T. Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C- methyleneribonucleosides. Tetrahedron Lett. 1998, 39, 5401-5404.
32. Koshkin, A.A.; Singh, S.K.; Nielsen, P.; Rajwanishi, V.K.; Kumar, R.; Meldgaard, M.; Olsen, C.E.; Wengel, J. Novel convenient syntheses of LNA [2.2.1]bicyclo nucleosides. Tetrahedron 1998, 54, 3607-3630.
33. Mohamadi, F.; Richard, N.G.J.; Guida, W.C.; Liskamp, R.; Lipton, M.; Caulfield, C.; Chang, G.; Hendrickson, T.; Still, W.C. MacroModel - An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 1990, 11, 440-467.
34. McDonald, D.Q.; Still, W.C. AMBER* torsional parameters for the peptide backbone. Tetrahedron Lett. 1992, 33, 7743-7746.
35. Salet, C.; DeSa E Melo TM, Bensasson, R.; Land, E. J. Photophysical properties of aminoethylpsoralen in presence and absence of DNA. Biochem. Biophys. Act. 1980, 607, 379-383.
36. Jackson, A.L.; Bartz, S.R.; Schelter, J.; Kobayashi, S.V.; Burchard, J.; Mao, M.; Li, B.; Cavet, G.; Linsley, P.S. Expression profiling reveals off target gene regulation by RNAi. Nat. Biol. 2003, 21, 635-637.
37. Saxene, S.; Jonsson, Z.O.; Dutta, A. Small RNAs with imperfect match to endogenous mRNA repress translation. J. Biol. Chem. 2003, 278, 44312-44319.
38. Scacheri, P.C.; Rozenblatt-Rosen, O.; Caplen, N.J.; Wolfsberg, T.G.; Umayam, L.; Lee, J.C.; Hughes, C.M.; Shanmugam, K.S.; Bhattacharjee, A.; Meyerson, M.; Collins, F.S. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. USA 2004, 101, 1892-1897.